Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection
Journal of Clinical Apheresis · 2026-12 · 41 (6)
DOI: 10.1002/jca.70205 ↗At a glance
Journal article in Journal of Clinical Apheresis, published online on 2026-11-01. Written by Biyu Wei and 4 co-authors. Institution: Department of Transfusion Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Major MEDLINE topics: Hypokalemia, Multiple Myeloma, Peripheral Blood Stem Cell Transplantation, Peripheral Blood Stem Cells. 24 references. Funded by: Natural Science Foundation of Fujian Province.
Abstract (original language)
Autologous peripheral blood stem cell (APBSC) collection is a standard procedure for patients with multiple myeloma (MM) undergoing hematopoietic stem cell transplantation. Hypokalemia is a frequently observed but underappreciated complication during apheresis, with limited evidence on its incidence and risk factors. To determine the incidence of hypokalemia following APBSC collection in MM patients and to identify independent risk factors. This retrospective cohort study consecutively enrolled 109 MM patients who underwent their first APBSC collection at Union Hospital, Fujian Medical University, between January 2018 and December 2022. All patients received prophylactic potassium supplementation during collection. Patients were stratified by serum potassium measured 2 h postprocedure: hypokalemia (< 3.5 mmol/L; n = 59) and normokalemia (3.5–5.0 mmol/L; n = 50). Variables with p < 0.10 in univariate analysis were entered into multivariable logistic regression with backward elimination. Post‐APBSC serum potassium was significantly lower than baseline (3.46 ± 0.43 vs. 3.85 ± 0.22 mmol/L; p < 0.001). Hypokalemia developed in 59 patients (54.1%): 48 mild (81.4%), nine moderate (15.3%), and two severe (3.4%). Three independent predictors were identified by multivariable analysis: higher body mass index (BMI) (OR 1.217; 95% CI 1.030–1.439; p = 0.021), higher hematocrit (OR 1.119; 95% CI 1.032–1.213; p = 0.006), and lower preprocedure serum potassium (OR 1.43 per 0.1 mmol/L decrease; 95% CI 1.15–1.78; p = 0.001). The model demonstrated adequate calibration (Hosmer–Lemeshow p = 0.635) and explained 24.6% of variance (Nagelkerke R 2 = 0.246). Hypokalemia affects over half of MM patients undergoing APBSC collection. Preprocedure risk factors (BMI, hematocrit, baseline potassium) may help identify high‐risk patients for whom intensified electrolyte monitoring and individualized supplementation strategies are warranted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Transfusion Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Department of Radiology, Xiamen First Clinical Medical College of Fujian Medical University, Xiamen, Fujian, China.
- Department of Radiology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
ORCID profiles: Biyu Wei, Jingyi Xia, Zhiyi Zheng, Qinghua Huang, Jianfang Liu
Funding
- Natural Science Foundation of Fujian Province
Cite
APA
Wei, B., Xia, J., Zheng, Z., Huang, Q., & Liu, J. (2026). Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection. Journal of Clinical Apheresis, 41(6). https://doi.org/10.1002/jca.70205
Vancouver
Wei B, Xia J, Zheng Z, Huang Q, Liu J. Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection. Journal of Clinical Apheresis. 2026;41(6). doi:10.1002/jca.70205
BibTeX
@article{Wei2026,
author = {Wei, Biyu and Xia, Jingyi and Zheng, Zhiyi and Huang, Qinghua and Liu, Jianfang},
title = {Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection},
journal = {Journal of Clinical Apheresis},
year = {2026},
volume = {41},
number = {6},
doi = {10.1002/jca.70205}
}
EUVIMED